| Bioactivity | PROTAC PD-L1 degrader-2 is an orally available, HPK1-targeting PROTAC that enhances PD-L1 antibody therapy[1]. |
| Target | MAP4K1/HPK1 |
| Formula | C43H42N8O5 |
| Molar Mass | 750.84 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |